Long Term Durability and Safety of Dual IO in NSCLC

WCLC 2022 Conference Coverage
D

WCLC 2022 on Modifiable Biomarkers of Response to Immune Checkpoint Inhibitor Treatment in NSCLC

By WCLC 2022 Conference Coverage FEATURING Daniel Spakowicz
By WCLC 2022 Conference Coverage FEATURING Daniel Spakowicz
159 views
August 23, 2022
0 Comments
Login to view comments. Click here to Login
09:22

2021 ASCO Review on Nivo + Ipi vs. Chemo as 1L Treatment for Advance…

Luis Paz-Ares

609 views
09:18

1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alone (4 Cycles) in mNSC…

Filippo de Marinis

494 views
11:11

2021 ASCO Update on 1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alon…

Tom John

427 views
04:06

1L Nivo+Ipi+Chemo for Patients With Advanced NSCLC and Brain Mets: R…

ecancer

D. Carbone

655 views
05:22

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

ecancer

S. Peters

362 views
07:25

ASCO 2021 Update on IO in NSCLC: Considering Data From the Key Trials

ecancer

L. Raez

69 views
31:18

2021 ASCO Updates on Lung Cancer: (Neo)adjuvant Therapy, Metastatic …

UAB Medicine Hematology and Oncology Highlights 2021

A. Hegde

102 views
19:26

Standard 1L Treatment of Advanced NSCLC in 2021: IO Combination & Mo…

Mariam Alexander

629 views
20:10

Epidemiological Shifts in Lung Cancers: Trends in Treatment and Diag…

Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

E. David

162 views
14:53

Serum Proteomic Signature & Advanced NSCLC: Can It Be Used as an Out…

Northwestern Medicine Oncology and Hematology

Y. Chae

417 views
36:33

Neoadjuvant Treatment of NSCLC With Immune CPIs: Biological Understa…

CECOG Academy

C. Zielinski

194 views
17:55

USC Updates on RT for mNSCLC: Consolidative Local Therapy

Keck School of Medicine of USC Advancing Knowledge in Multidisciplinary Lung Cancer Care

M. Daly

87 views
21:04

Metastatic NSCLC: Approaches and Updates

2022 West Oncology Conference

J. Porter

1.1K views
07:37

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

277 views
24

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

19 views
01:18

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

87 views
13:01

ASCO 2022 on Immunotherapy Updates in Advanced NSCLC

Nebraska Oncology Society

J. Brahmer

1.9K views
09:18

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

476 views
01:46

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

20 views
06:03

Penn Medicine mNSCLC Updates

Penn Medicine Abramson Cancer Center

M. Marmarelis

99 views
10:59

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

145 views
01:24

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

96 views
16:37

ASCO 2022 Early Stage NSCLC Updates

Lung Cancer Europe (LuCE)

J. Naidoo

338 views
47:32

1L Therapy for Advanced/Metastatic PD-L1 Negative (TPS <1%) NSCLC

Aaron Franke

576 views
01:43

Lecture Summary - WCLC 2022 on Modifiable Biomarkers of Response to …

WCLC 2022 Conference Coverage

D. Spakowicz

7 views
17:29

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

ILCC 2022 Conference Coverage

T. Mitsudomi

1.1K views
07:36

ESMO 2022 on the CheckMate 9LA Study Results: Clinical Outcomes in P…

ESMO 2022 Conference Coverage

T. John

259 views
23:21

Neoadjuvant Chemotherapy and Immunotherapy for NSCLC

Giuseppe Banna

133 views
08:17

Neoadjuvant Nivo + Platinum-Doublet Chemo vs. Chemo for Resectable (…

Nicolas Girard

92 views